Telix buys ITM in bid to create a ‘radiopharmaceutical powerhouse’

AI Summary

Telix has acquired ITM in a $1.65 billion deal, combining their pipelines and manufacturing networks to strengthen their position in the radiopharmaceutical industry. This acquisition is considered a strategic move to dominate the market in this sector.

Worth $1.65 billion up front, the deal combines two large pipelines and manufacturing networks, helping Telix potentially “corner the industry” for radiopharmaceuticals, one analyst wrote.